Pharma Focus Asia

Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

Turkish Cargo Now Ranks the 3rd Among the Global Air Cargo Carriers

Tuesday, July 18, 2023

Turkish Cargo the air cargo brand of Turkish Airlines ranked the rd among the leading air cargo carriers in the world in the wake of a prospering performance in May

Roquette signs agreement to acquire Qualicaps and reinforce its global position in the pharmaceutical industry

Friday, July 28, 2023

Roquette a global leader in plantbased ingredients and pharmaceutical excipients announced today an agreement to acquire Qualicaps and reinforce its position as a major supplier to the pharmaceutical industry The combination of the two businesses wil...

Qualicaps Welcomes The Signature Of An Agreement To Join Roquette Group

Saturday, July 29, 2023

The Mitsubishi Chemical Group the MCG Group announced today the signature of a share transfer agreement with Roquette a global leader of pharmaceutical excipients headquartered in France for the transfer of all shares of Qualicaps The transaction is...

GARDP and Bugworks join forces to accelerate development of a novel antibiotic to treat serious bacterial infections

Saturday, July 29, 2023

The Global Antibiotic Research Development Partnership GARDP is joining forces with Bugworks Research Inc Bugworks an innovative clinicalstage biopharmaceutical company with research and development facilities inBangalore India to accelerate the dev...

First Patient Dosed in Chemotherapy-Free Triple Combination Phase II Trial Targeting Soft Tissue Sarcoma

Saturday, July 29, 2023

Immutep Limited ASX IMM NASDAQ IMMP Immutep or the Company a clinicalstage biotechnology company developing novel LAG immunotherapies for cancer and autoimmune disease today announces the first patient has been enrolled and safely dosed in EFTISARCNE...

Immuno Cure Completed US$12M First Close of Series A Financing, led by AEF GBA Fund managed by Gobi Partners GBA

Friday, July 28, 2023

Immuno Cure BioTech Immuno Cure a biotechnology group based in the Hong Kong Science Park is pleased to announce today that it has closed the US million tranche in the US million Series A fundraising round Led by the AEF Greater Bay Area Fund that Go...

Acceptance Of Clinical Trial Application For The Recbio's Novel Adjuvanted Recombinant Shingles Vaccine REC610 In China

Thursday, July 27, 2023

Jiangsu Recbio Technology Co Ltd theBoard is pleased to announce that the Group has recently received the notice of acceptance acceptance number CXSL issued by National Medical Products Administration NMPA pursuant to which the clinical trial applica...

PharmAbcine Announces First Patient Dosed in the Phase I Clinical Trial of Its Novel TIE2 Agonistic Antibody in nAMD

Thursday, July 27, 2023

PharmAbcine Inc KOSDAQ ks a clinicalstage biotech company focusing on the development of nextgeneration antibody therapeutics announced today that the first patient has been dosed in the Phase I clinical trial of PMC the Companys novel TIE agonistic...

Everest Medicines Announces Commercial Launch and First Prescription for XERAVA® in China

Thursday, July 27, 2023

Everest Medicines HKEX HK Everest or the Company a biopharmaceutical company focused on the development manufacturing and commercialization of innovative medicines and vaccines announced today XERAVA eravacycline has been successfully launched in Chi...

Griffith University and Gene Company partner to create exciting RNA-based COVID anti-viral

Thursday, July 27, 2023

Griffith University has entered into a million commercial partnership with Gene Company Pty Ltd to further develop a new drug treatment for SARSCoV the virus responsible for COVID